Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-792-3 | CAS number: 151-50-8
Endpoint summary
Administrative data
Description of key information
The systemic toxicity of cyanides is sufficiently high that acute toxicity and possibly lethality occur before irritation can develops. KCN can be converted to HCN on moist skin and in the eye, and is absorbed via the skin and eye.
Key value for chemical safety assessment
Additional information
The systemic toxicity of cyanides is sufficiently high that systemic intoxication and death are likely to occur before the development of inflammatory irritation effects on the skin or eye. Testing for skin and eye irritation is not feasible, due to the high acute toxicity of HCN derived from KCN. The amount of test material required in a standard skin and eye irritation study (500 and 100 mg/animal, respectively) is considerably above the level of systemic toxicity of cyanide. For example, for HCN, the dermal LD50 in rabbits is 2.34 mg/kg bw in abraded skin, and the ocular toxicity is 1.04 mg/kg bw. Recommended precautions for handling of HCN include respiratory protection to prevent lung inhalation, and barrier protection for eye and skin.
Effect level: empty Endpoint conclusion: Adverse effect observed
Effect level: empty Endpoint conclusion: Adverse effect observed
Justification for classification or non-classification
Classification as a skin or eye irritant is not appropriate as no reliable data exists. The extremely high acute toxicity of HCN and its salts indicates that it is classified as an acute toxicant, with appropriate warnings to avoid skin and eye contact. In this way, irritation effects will be precluded.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
